Molecular strategies for Angelman syndrome explored in study

A new review sheds light on the complex molecular mechanisms behind Angelman syndrome (AS), a rare neurogenetic disorder, and explores how cutting-edge gene-targeting therapies may offer more effective treatment options in the future.

This article was originally published on MedicalXpress.com

You may also be interested in:

Read More:

Lawyers Lookup